±±¾©Ê¯ÓÍ»¯¹¤Ñ§Ôº2026ÄêÑо¿ÉúÕÐÉú½ÓÊÕµ÷¼Á¹«¸æ
²é¿´: 642  |  »Ø¸´: 9
µ±Ç°Ö÷ÌâÒѾ­´æµµ¡£
µ±Ç°Ö»ÏÔʾÂú×ãÖ¸¶¨Ìõ¼þµÄ»ØÌû£¬µã»÷ÕâÀï²é¿´±¾»°ÌâµÄËùÓлØÌû

qiuzhen3602

Í­³æ (СÓÐÃûÆø)

[½»Á÷] Ͷ¸åÇóÖú

´ó¼Ò°ï°ï棬¿´¿´±à¼­µÄÐÅ:
Reviewers' comments on your work have now been received.

Based on these comments we regret to inform you that we must reject this paper from further consideration for publication. In addition to the comments shown below, all reviewers indicated that the originality and overall priority of the manuscript are low. Due to the large number of submitted manuscripts only papers with high priority can be published.
We suggest that you use the reviewers´ comments as a guide if you prepare this manuscript for submission to another journal.
ͶµÄÔÓÖ¾ÊÇEuropean Journal of Pharmaceutical Sciences£¬ÈýλÉó¸åÈËÌáÁ˺ܶàÎÊÌ⣬¸öÈËÈÏΪ¶¼²»ÊÇÊ²Ã´ÖØ´óÎÊÌ⣬×ܽáÆðÀ´´ó²¿·Ö¶¼ÊÇÎÄÕµÄһЩÄÚÈݽ»´úµÄ²»ÊǺÜÇå³þ£¬ÓïÑÔÐèÒªÔÙÕå×á£Éó¸åÈ˵Ĵ󲿷ÖÎÊÌâÎÒ¶¼¿ÉÒÔ¼ÓÒÔ½âÊͺÍÐ޸ģ¬ÎÒ»¹ÏëÔÙͶ¸ÃÔÓÖ¾£¬´ó¼Ò¸øµãÒâ¼û£¬¿ÉÐÐÂ𣿾õµÃ»áÓкÃÏûÏ¢Âð£¿ÕâÊDZ¾È˵ÚÒ»´ÎͶ¸å£¬ÕûÌìÌáÐĵõµ¨µÄ¡£¸÷λ´óÏÀ¸Ï¿ì¾È¾ÈÎÒ°É¡£
»Ø¸´´ËÂ¥

» ²ÂÄãϲ»¶

ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

ÎÞÖøÐÄ

ľ³æ (ÖøÃûдÊÖ)

¡ï
Сľ³æ(½ð±Ò+0.5):¸ø¸öºì°ü£¬Ð»Ð»»ØÌû½»Á÷
»»¸öÔÓÖ¾£¬¼ÈÈ»Éó¸åÈË˵´´ÐÂÐÔ²»¹»
Ö»ÄܽµµÍÔÓÖ¾µµ´ÎÁË
×£¸£¡­¡­
9Â¥2010-03-11 15:34:07
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû
²é¿´È«²¿ 10 ¸ö»Ø´ð

Ñà¹Âºè

½ð³æ (ÖøÃûдÊÖ)

¡ï
Сľ³æ(½ð±Ò+0.5):¸ø¸öºì°ü£¬Ð»Ð»»ØÌû½»Á÷
ÎÒ½¨ÒéÄ㻻Ͷ±ðµÄÆÚ¿¯£¬ÒòΪ¾Ü¾øÄãµÄÔ­ÒòÊÇÕâ¸ö

all reviewers indicated that the originality and overall priority of the manuscript are low.
ÈËÈôÎÞÃû,±ã¿ÉרÐÄ
2Â¥2010-03-11 10:48:53
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

»¨·É·É

ÖÁ×ðľ³æ (ÖªÃû×÷¼Ò)

¡ï
Сľ³æ(½ð±Ò+0.5):¸ø¸öºì°ü£¬Ð»Ð»»ØÌû½»Á÷
Â¥Ö÷×ÐϸÐ޸ģ¬Ò»Ò»»Ø¸´ÈýλÉó¸åÈË£¬½¨Ò黹ÊÇͶÕâ¸öÔÓÖ¾£¬»¹ÊÇÓлú»áµÄ
ûÓÐÉ¡µÄº¢×Ó±ØÐëŬÁ¦±¼ÅÜ
3Â¥2010-03-11 10:50:44
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

yf0534

ÖÁ×ðľ³æ (Ö°Òµ×÷¼Ò)

¡ï
Сľ³æ(½ð±Ò+0.5):¸ø¸öºì°ü£¬Ð»Ð»»ØÌû½»Á÷
±à¼­ËµµÄºÜÇå³þÁË£¬ËµÂ¥Ö÷µÄÎÄÕµµ´Î²»¹»£¬¶øÇÒͶ¸Ã¿¯ÎïµÄÎÄÕºܶ࣬¥Ö÷»¹ÊǸÄͶÆäËû¿¯Îï±È½ÏºÃ£¬
4Â¥2010-03-11 10:50:50
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû
×î¾ßÈËÆøÈÈÌûÍÆ¼ö [²é¿´È«²¿] ×÷Õß »Ø/¿´ ×îºó·¢±í
[¿¼ÑÐ] ²ÄÁϹ¤³Ì302·ÖÇóµ÷¼Á +6 zyxÉϰ¶£¡ 2026-04-04 6/300 2026-04-05 07:57 by qlm5820
[¿¼ÑÐ] 081700£¬311£¬Çóµ÷¼Á +11 ¶¬Ê®Èý 2026-04-04 11/550 2026-04-04 22:24 by à£à£à£0119
[¿¼ÑÐ] 0703×Ü·Ö331Çóµ÷¼Á +9 ZY-05 2026-04-04 12/600 2026-04-04 22:10 by ZY-05
[¿¼ÑÐ] 301Çóµ÷¼Á +18 ÂæÍÕÄÐÈË 2026-04-02 18/900 2026-04-04 20:33 by À¶ÔÆË¼Óê
[¿¼ÑÐ] Ò»Ö¾Ô¸9²ÄÁÏѧ˶297ÒѹýÁù¼¶Çóµ÷¼ÁÍÆ¼ö +8 adaie 2026-04-04 9/450 2026-04-04 17:37 by oooqiao
[¿¼ÑÐ] Ò»Ö¾Ô¸±±½»´ó²ÄÁϹ¤³Ì×Ü·Ö358 +6 cs0106 2026-04-03 6/300 2026-04-04 11:20 by w_xuqing
[¿¼ÑÐ] 350Ò»Ö¾Ô¸±±¾©º½¿Õº½Ìì´óѧ08500²ÄÁÏ¿ÆÑ§Ó빤³ÌÇóµ÷¼Á +5 kjnasfss 2026-04-03 5/250 2026-04-03 22:29 by Î޼ʵIJÝÔ­
[¿¼ÑÐ] 295Çóµ÷¼Á +3 ÉÐټѽ 2026-04-03 4/200 2026-04-03 21:23 by zhq0425
[¿¼ÑÐ] 301Çóµ÷¼Á +14 A_JiXing 2026-04-01 14/700 2026-04-03 18:31 by lsÁõ˧
[¿¼ÑÐ] ¹¤¿Æ341·Öµ÷¼Á +3 Âå¶àÂÞ 2026-04-03 3/150 2026-04-03 14:20 by 1753564080
[¿¼ÑÐ] Çóµ÷¼Á +3 ÐÄÏëÊÂ³É¿É 2026-04-03 3/150 2026-04-03 11:22 by wangjy2002
[¿¼ÑÐ] 085801 ×Ü·Ö275 ±¾¿ÆÐÂÄÜÔ´ Çóµ÷¼Á +19 bradoner 2026-04-01 23/1150 2026-04-03 10:07 by linyelide
[¿¼ÑÐ] 312Çóµ÷¼Á +4 ÉÞÔÂÉ« 2026-04-02 5/250 2026-04-03 08:21 by fangshan711
[¿¼²©] É격ÇóÖú +3 Reee1Llll 2026-04-01 3/150 2026-04-02 22:29 by ÕâÊÇÒ»¸öÎÞÁĵÄê
[¿¼ÑÐ] 346Çóµ÷¼Á +5 Ö£³ÏÀÖ 2026-04-02 5/250 2026-04-02 16:38 by SZW_UJN
[¿¼ÑÐ] ÄÜÔ´¶¯Á¦ µ÷¼Á +3 ²»ÆÆ²»Á¢0 2026-04-02 3/150 2026-04-02 12:46 by ffffjjjj
[¿¼ÑÐ] Ò»Ö¾Ô¸±±¾©¿Æ¼¼´óѧ085601²ÄÁϹ¤³ÌÓ¢Ò»Êý¶þ³õÊÔ×Ü·Ö335Çóµ÷¼Á +9 Ë«ÂíβƦÀϰå2 2026-04-01 9/450 2026-04-02 12:14 by oooqiao
[¿¼ÑÐ] 0856³õÊÔ324·ÖÇóµ÷¼Á +6 ÏëÉÏѧÇóµ÷ 2026-04-01 6/300 2026-04-02 11:42 by ÐÇ¿ÕÐÇÔÂ
[¿¼ÑÐ] 279Çóµ÷¼Á +6 ѧ¶øË¼ÙâÖª 2026-04-01 6/300 2026-04-02 09:16 by vgtyfty
[¿¼²©] 26ÄêÉ격 +3 staryer 2026-03-30 4/200 2026-04-01 23:21 by ai4pharm
ÐÅÏ¢Ìáʾ
ÇëÌî´¦ÀíÒâ¼û